Published in Obstet Gynecol on December 01, 2013
SNP-based Microdeletion and Aneuploidy RegisTry (SMART) (SMART) | NCT02381457
Replacement of Cytogenetics by aCGH in Prenatal Diagnosis | NCT03955588
Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial. JAMA (2014) 3.50
Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA. Proc Natl Acad Sci U S A (2015) 0.99
Whole-genome array CGH evaluation for replacing prenatal karyotyping in Hong Kong. PLoS One (2014) 0.86
Limited Clinical Utility of Non-invasive Prenatal Testing for Subchromosomal Abnormalities. Am J Hum Genet (2015) 0.85
Exome Sequencing in Fetuses with Structural Malformations. J Clin Med (2014) 0.85
Prenatal SNP array testing in 1000 fetuses with ultrasound anomalies: causative, unexpected and susceptibility CNVs. Eur J Hum Genet (2015) 0.83
Association of copy number variants with specific ultrasonographically detected fetal anomalies. Obstet Gynecol (2014) 0.82
Paired-Duplication Signatures Mark Cryptic Inversions and Other Complex Structural Variation. Am J Hum Genet (2015) 0.82
Comprehensive genetic analysis of pregnancy loss by chromosomal microarrays: outcomes, benefits, and challenges. Genet Med (2016) 0.80
Comparing genetic counselor's and patient's perceptions of needs in prenatal chromosomal microarray testing. Prenat Diagn (2015) 0.80
Analyzing the most frequent disease loci in targeted patient categories optimizes disease gene identification and test accuracy worldwide. J Transl Med (2015) 0.79
Counseling Challenges with Variants of Uncertain Significance and Incidental Findings in Prenatal Genetic Screening and Diagnosis. J Clin Med (2014) 0.78
Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders. Cold Spring Harb Perspect Med (2015) 0.78
Structural Chromosomal Rearrangements Require Nucleotide-Level Resolution: Lessons from Next-Generation Sequencing in Prenatal Diagnosis. Am J Hum Genet (2016) 0.77
Copy number variants, aneuploidies, and human disease. Clin Perinatol (2015) 0.76
Microarray Technology for the Diagnosis of Fetal Chromosomal Aberrations: Which Platform Should We Use? J Clin Med (2014) 0.76
Twin pregnancy complicated by esophageal atresia, duodenal atresia, gastric perforation, and hypoplastic left heart structures in one twin: a case report and review of the literature. J Med Case Rep (2017) 0.75
Genetic counseling for men with recurrent pregnancy loss or recurrent implantation failure due to abnormal sperm chromosomal aneuploidy. J Assist Reprod Genet (2016) 0.75
Pre- and post-test genetic counseling for chromosomal and Mendelian disorders. Semin Perinatol (2015) 0.75
Recent advances in prenatal genetic screening and testing. F1000Res (2016) 0.75
Utility of ultrasound examination at 10-14 weeks prior to cell-free DNA screening for fetal aneuploidy. Ultrasound Obstet Gynecol (2017) 0.75
A genome-wide screen for copy number alterations in an adolescent pilot cohort with müllerian anomalies. Fertil Steril (2014) 0.75
Prenatal screening of cytogenetic anomalies - a Western Indian experience. BMC Pregnancy Childbirth (2015) 0.75
What results to disclose, when, and who decides? Healthcare professionals' views on prenatal chromosomal microarray analysis. Prenat Diagn (2016) 0.75
Performance Evaluation of NIPT in Detection of Chromosomal Copy Number Variants Using Low-Coverage Whole-Genome Sequencing of Plasma DNA. PLoS One (2016) 0.75
"Something Extra on Chromosome 5": Parents' Understanding of Positive Prenatal Chromosomal Microarray Analysis (CMA) Results. J Genet Couns (2016) 0.75
Prenatal diagnosis of complete maternal uniparental isodisomy of chromosome 4 in a fetus without congenital abnormality or inherited disease-associated variations. Mol Cytogenet (2015) 0.75
Prenatal management, pregnancy and pediatric outcomes in fetuses with septated cystic hygroma. Braz J Med Biol Res (2014) 0.75
Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol (2012) 2.72
ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis. Obstet Gynecol (2011) 1.88
ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome. Obstet Gynecol (2010) 1.33
ACOG committee opinion. No. 338: Screening for fragile X syndrome. Obstet Gynecol (2006) 1.23
Committee Opinion No. 478: Family history as a risk assessment tool. Obstet Gynecol (2011) 0.94
Committee Opinion No. 481: Newborn screening. Obstet Gynecol (2011) 0.93
ACOG Committee Opinion No. 449: Maternal phenylketonuria. Obstet Gynecol (2009) 0.84
ACOG Committee Opinion No. 488: Pharmacogenetics. Obstet Gynecol (2011) 0.75